Literature DB >> 21463634

Neddylation-induced conformational control regulates cullin RING ligase activity in vivo.

Boon Kim Boh1, Peter G Smith, Thilo Hagen.   

Abstract

Cullin RING ligases (CRLs) constitute the largest family of ubiquitin ligases with diverse cellular functions. Conjugation of the ubiquitin-like molecule Nedd8 to a conserved lysine residue on the cullin scaffold is essential for the activity of CRLs. Using structural studies and in vitro assays, it has been demonstrated that neddylation stimulates CRL activity through conformational rearrangement of the cullin C-terminal winged-helix B domain and Rbx1 RING subdomain from a closed architecture to an open and dynamic structure, thus promoting ubiquitin transfer onto the substrate. Here, we tested whether the proposed mechanism operates in vivo in intact cells and applies to other CRL family members. To inhibit cellular neddylation, we used a cell line with tetracycline-inducible expression of a dominant-negative form of the Nedd8 E2 enzyme or treatment of cells with the Nedd8 E1 inhibitor MLN4924. Using these cellular systems, we show that different mutants of Cul2 and Cul3 and of Rbx1 that confer increased Rbx1 flexibility mimic neddylation and rescue CRL activity in intact cells. Our findings indicate that in vivo neddylation functions by inducing conformational changes in the C-terminal domain of Cul2 and Cul3 that free the RING domain of Rbx1 and bridge the gap for ubiquitin transfer onto the substrate.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463634     DOI: 10.1016/j.jmb.2011.03.023

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  The cullin-4 complex DCDC does not require E3 ubiquitin ligase elements to control heterochromatin in Neurospora crassa.

Authors:  Keyur K Adhvaryu; Jordan D Gessaman; Shinji Honda; Zachary A Lewis; Paula L Grisafi; Eric U Selker
Journal:  Eukaryot Cell       Date:  2014-10-31

Review 2.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

3.  COP9 signalosome subunits protect Capicua from MAPK-dependent and -independent mechanisms of degradation.

Authors:  Annabelle Suisse; DanQing He; Kevin Legent; Jessica E Treisman
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

4.  Mono-ubiquitination drives nuclear export of the human DCN1-like protein hDCNL1.

Authors:  Kenneth Wu; Hua Yan; Lei Fang; Xinjiang Wang; Cathie Pfleger; Xuejun Jiang; Lan Huang; Zhen-Qiang Pan
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

5.  Inhibition of neddylation causes meiotic arrest in mouse oocyte.

Authors:  Mo Yang; Yimei Jin; Siying Fan; Xiaoling Liang; Jialin Jia; Zhongzhou Tan; Tao Huang; Yuan Li; Teng Ma; Mo Li
Journal:  Cell Cycle       Date:  2019-05-21       Impact factor: 4.534

6.  The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.

Authors:  Annabelle Suisse; Miklós Békés; Tony T Huang; Jessica E Treisman
Journal:  Fly (Austin)       Date:  2018-02-09       Impact factor: 2.160

Review 7.  Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases.

Authors:  Holger K Eltzschig; Donna L Bratton; Sean P Colgan
Journal:  Nat Rev Drug Discov       Date:  2014-11       Impact factor: 84.694

Review 8.  Structural and functional insights to ubiquitin-like protein conjugation.

Authors:  Frederick C Streich; Christopher D Lima
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

Review 9.  Hypoxia and Mucosal Inflammation.

Authors:  Sean P Colgan; Eric L Campbell; Douglas J Kominsky
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

10.  Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response.

Authors:  Stefan F Ehrentraut; Douglas J Kominsky; Louise E Glover; Eric L Campbell; Caleb J Kelly; Brittelle E Bowers; Amanda J Bayless; Sean P Colgan
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.